Leptospirosis vaccines: past, present, and future

Area of Science:

• Veterinary immunology
• Microbial pathogenesis
• Vaccine development

Background:

• Current killed whole cell Leptospira vaccines exhibit limited efficacy due to specificity for particular serovars.
• There is a need for broadly protective vaccine candidates against pathogenic Leptospira.
• Identifying conserved leptospiral antigens is crucial for developing effective vaccines.

Purpose of the Study:

• To summarize current findings on conserved leptospiral antigens that induce cross-protective immunity.
• To explore the potential of reverse vaccinology in identifying novel vaccine candidates.
• To review the roles of humoral and cell-mediated immunity in Leptospira protection.

Main Methods:

• Review of published literature on leptospiral antigens and vaccine efficacy.
• Analysis of full-length genome sequences of Leptospira strains.
• Application of reverse vaccinology principles for candidate identification.

Main Results:

• Several leptospiral antigens conserved among pathogenic strains have been identified.
• These conserved antigens have demonstrated the ability to induce protective immunity in animal models.
• Reverse vaccinology approaches are yielding promising vaccine candidates.

Conclusions:

• Conserved leptospiral antigens represent a promising strategy for developing broadly protective vaccines.
• Further research into cell-mediated immunity is warranted for a comprehensive understanding of protection.
• Novel vaccine candidates identified through genomic and reverse vaccinology approaches show potential for improved Leptospira prevention.